Marie Vanhuyse

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Lamellarin D: a novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux

Marie Vanhuyse, Jérôme Kluza, Christèle Tardy et al. · Cancer Letters · 2004 · 84 citations

Pharmaceutical Science, Biochemistry, Medicine +8

Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer

Emmanuel S. Antonarakis, Scott T. Tagawa, Giuseppe Galletti et al. · Journal of Clinical Oncology · 2017 · 81 citations · Full text

Chemotherapy-induced amenorrhea: influence on disease-free survival and overall survival in receptor-positive premenopausal early breast cancer patients

Marie Vanhuyse, Charles Fournier, Jacques Bonneterre · Annals of Oncology · 2005 · 49 citations · Full text

Breast Oncology, Oncology, Cancer Management +8

Phase 1 Trial of Atezolizumab Plus Trimodal Therapy in Patients With Localized Muscle-Invasive Bladder Cancer

Gautier Marcq, Luís Souhami, Fabio Cury et al. · International Journal of Radiation Oncology*Biology*Physics · 2021 · 39 citations

Urology, Genitourinary Cancer, Medicine +5